| abstract |
The invention provides a kind of anti-tumor necrosis factor Humanized monoclonal antibodies and application thereof, described anti-tumor necrosis factor Humanized monoclonal antibodies compares existing mouse chimera antibodies, while the ability maintaining antibody recognition antigen, greatly reduce the immunogenicity of murine antibody, thus improve the security of antibody in clinical application. |